Presentation is loading. Please wait.

Presentation is loading. Please wait.

MOQC Update Douglas Blayney, MD Physician Lead, MOQC Transforming Oncology Care Together.

Similar presentations


Presentation on theme: "MOQC Update Douglas Blayney, MD Physician Lead, MOQC Transforming Oncology Care Together."— Presentation transcript:

1 MOQC Update Douglas Blayney, MD Physician Lead, MOQC Transforming Oncology Care Together

2 MOQC RECOGNITION Transforming Oncology Care Together

3 Improving Extravasation Management Working Group Allegiance Health Hematology & Oncology Cancer & Hematology Centers of Western Michigan Karmanos Cancer Institute Sparrow Regional Cancer Center University of Michigan Cancer Center West Michigan Cancer Center

4 Annual Competency Assessment Tools Working Group Toledo Clinic Hematology Oncology West Michigan Cancer Center

5 Improving Symptom Management Quality Initiative Southwest Michigan Oncology Associates St. John Lymphoma Clinic St. John Health Partners – Great Lakes Cancer Management Specialists

6 QOPI Certified Practices Sparrow Regional Cancer Center Toledo Clinic Hematology Oncology Northern Michigan Hematology Oncology West Michigan Cancer Center Southwest Michigan Oncology Associates University of Michigan Cancer Center

7 QOPI Certified Practices NEW IN FALL 2012 Five New Practices!! Marquette General Hematology / Oncology  Chippewa  Escanaba  Hancock  Marquette  North Country

8 MOQC OVERALL PERFORMANCE Transforming Oncology Care Together

9 Infertility Risks & Preservation Options Not Documented

10

11 Pal Care Demo 1 Pain Initiative

12 Palliative Care Demonstration Project Initial Results

13

14 IMPROVING PERFORMANCE ON HOSPICE AND PALLIATIVE CARE REFERRALS AND DISCUSSIONS QOPI MEASURE: IDENTIFYING BARRIERS AND COUNTERMEASURES Transforming Oncology Care Together

15 ON THE HORIZON: Transforming Oncology Care Together

16 New QOPI ® Test Measures: Choosing Wisely Breast Cancer Diagnosis (stage I, IIA, or II B) – PET, CT, or radionuclide bone scan (lower is better) Breast Cancer Surveillance after curative treatment – PET, CT, or radionuclide bone scan within 12 months of diagnosis (lower is better) – Serum tumor marker surveillance within 12 months of diagnosis (lower is better)

17 New QOPI ® Test Measures: Choosing Wisely G-CSF use in metastatic – Colon cancer (lower is better) – NSCLC cancer (lower is better) – Breast cancer (lower is better) Chemotherapy administered to patients with metastatic solid tumor with performance status of 3,4 or undocumented ( lower is better)

18 New with QOPI ® Certification Change from NHL to NSCLC module as required module to apply eQOPI Abstraction of measures from EHR Different measure set than “classic QOPI” – Look for pilot in late 2013 or early 2014

19 New with MOQC? QOPI Certification Mock Surveys Tobacco Cessation Initiative Goals of Care Initiative Application will be available in late spring Oral Chemotherapy Initiative with MSHO Application will be available in summer Initiatives eligible for ABIM Maintenance of Certification Part IV. Practice Performance Assessment credit designation


Download ppt "MOQC Update Douglas Blayney, MD Physician Lead, MOQC Transforming Oncology Care Together."

Similar presentations


Ads by Google